Is risk-based clinical trial monitoring too flexible for the regulators?

Is risk-based clinical trial monitoring too flexible for the regulators?

5 Minuten

Beschreibung

vor 13 Jahren
Risk-based monitoring for clinical trials was a hot topic at this
year’s PCT Europe thanks to recent draft guidances from the FDA and
the EMA.

Kommentare (0)

Lade Inhalte...

Abonnenten

15
15